🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today is #RareDiseaseDay, a global movement advancing equity in healthcare, diagnosis & treatment for people living with rare diseases. Join us! Show Your Colors to raise awareness, drive advocacy, improve care access and advance new treatment approaches. rarediseaseday.org

People with developmental disabilities are our neighbors, friends, and coworkers and should have equal access to opportunities. Let's celebrate their contributions this Developmental Disabilities Awareness Month and commit to #We're Here All Year! #NACDD #DDAwareness

Today is Purple Day 2025 💜 We’re wearing purple to #StandUpToSeizures and raise awareness for epilepsy. Join us in supporting research and transformative therapies — today and every day. #PurpleDay #StandUpToSeizures #Epilepsy

Tune in to hear Encoded’s Chief Medical Officer Salvador Rico PhD on The Genetics Podcast, discussing the challenges and rewards of working in gene therapy and his path to precision medicine drug development for neurological disorders.

Encoded has announced three presentations at #ASGCT2025 that underscore the strength of our vector engineering platform and demonstrate continued progress of the #AngelmanSyndrome, #Alzheimers / tauopathies and chronic pain programs. ow.ly/Um3R50VJkCx #GeneticMedicines

Today we shared new preclinical data highlighting the advancement of our programs for #Angelman syndrome, #Alzheimer’s disease/tauopathies & chronic pain—underscoring the power & versatility of our vector engineering platform. Visit our #ASGCT2025 posters. ow.ly/6mx550VRR7H

Join us for "ETX201: An AAV9-based Vectorized miRNA Therapeutic Candidate for Angelman Syndrome," at the American Society of Gene & Cell Therapy 28th Annual Meeting. Poster 547, Tuesday, May 13 at 6 pm CT. #ASGCT2025

We honor Dr. Charlotte Dravet, who identified the rare condition that now bears her name, Dravet syndrome, and transformed how childhood epilepsy is understood & treated. Her legacy lives on in every life improved by her dedication. #DrCharlotteDravet #DravetSyndrome #Dravet

Don't miss "Potent and Specific AAV9-miRNA Candidates Demonstrate Robust Reduction of Microtubule-associated Protein Tau (MAPT) in Non-Human Primates,” at the American Society of Gene & Cell Therapy 28th Annual Meeting. Poster 1440, on Wednesday, May 14 at 5:30 pm CT. #ASGCT2025

Join for "Developing an AAV-based Gene Therapy for Chronic Pain Through Identification of Potent and Selective Artificial miRNA Candidates to Knockdown SCN9A” at the American Society of Gene & Cell Therapy 28th Annual Meeting. Poster 1925. Thurs, May 15, at 5:30 pm CT. #ASGCT2025

On #ClinicalTrialsDay, we honor the patients, families, and professionals whose dedication drives progress. From volunteer participants to clinical research teams, your efforts are the foundation of advancing gene therapies for pediatric CNS disorders. ow.ly/ymqa50RNZrL

Join us at Epilepsy Therapies and Diagnostics Development (ETDD) XVIII Emma James, PhD MFPM (Hon), Encoded Therapeutics, will highlight our POLARIS clinical program in her presentation, “ETX101 for SCN1A+ Dravet Syndrome." Thurs, May 29 at 10:10 am ET #DravetSyndrome #Epilepsy

Today on #DravetAwarenessDay we join the community to Turn Awareness into Action. By raising awareness, we aim to support early diagnosis, connect families with resources, and reduce the isolation felt by those living with #DravetSyndrome. #DravetAwarenessMonth Dravet Syndrome Foundation

Still inspired by May’s Angelman Strong Walk — a powerful day with colleagues supporting the Angelman community. Now at ASF for the ASF/Dup15q Alliance Research Symposium (July 21–23), we’re proud to connect with families and advocates moving progress forward. #AngelmanStrong